Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors
about
Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing associationSpotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativaMedical and Surgical Treatment of Hidradenitis Suppurativa: A Review.Hidradenitis suppurativa: from pathogenesis to diagnosis and treatmentComorbidities of hidradenitis suppurativa (acne inversa).Increased prevalence of metabolic syndrome in patients with acne inversa.Hidradenitis suppurativa - a case report.Tumor necrosis factor inhibitors - state of knowledge.New topical photodynamic therapy for treatment of hidradenitis suppurativa using methylene blue niosomal gel: a single-blind, randomized, comparative study.European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.Acne inversa of the scrotum and penis - aggressive urological treatment.The off-label treatment of severe hidradenitis suppurativa with TNF-α inhibitors: a systematic review.Long-term efficacy of infliximab in hidradenitis suppurativa.Can animal skin diseases or current transgenic mice serve as a model for hidradenitis suppurativa?Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review.Adalimumab in treatment-resistant hidradenitis suppurativa following recurrence after extensive affected area excision: a review of biologics therapy.The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment.Adalimumab for the treatment of hidradenitis suppurativa/acne inversa.High burden of hospital resource utilization in patients with hidradenitis suppurativa in England: a retrospective cohort study using hospital episode statistics.Interferon-gamma (IFN-γ) is Elevated in Wound Exudate from Hidradenitis Suppurativa.Skin disorders associated with obesity in children and adolescents: a population-based study.Experience with ustekinumab for the treatment of moderate to severe hidradenitis suppurativa.Considering hidradenitis suppurativa as a bacterial biofilm disease.Metformin for the treatment of hidradenitis suppurativa: a little help along the way.Mild to moderate hidradenitis suppurativa treated with local excision and primary closure.Severe hidradenitis suppurativa treatment using platelet-rich plasma gel and Hyalomatrix.Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa.Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa.A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa.Leukaemic transformation in patients with haematological disease receiving tumour necrosis factor inhibitors.The Hidradenitis Suppurativa Priority Setting Partnership.Use of biologics in the treatment of hidradenitis suppurativa: a review of the Henry Ford Hospital experience.Development and initial psychometric evaluation of patient-reported outcome questionnaires to evaluate the symptoms and impact of hidradenitis suppurativa.
P2860
Q26745455-D02AF293-206E-4FD3-92EC-01B9B2B047CEQ28069719-808538DA-580E-47DA-9F8B-4A2EA2BCFFF5Q30234313-AD289602-B728-4F30-B161-67E169085294Q30234599-498BEB2B-199B-42F1-84FD-7F37D3C1E0E9Q33890939-6AE8E5C1-C9CE-4CCC-802B-863698DB5459Q34168423-9ED7EFAA-C174-40FC-99DC-EC199CC526CAQ34220292-54B10D10-165D-40BC-95B9-0A527B2B3766Q34974335-A6410FE7-C21C-4039-8D74-B634862C92DAQ35282209-AAF804E7-45ED-4A03-BECE-FB3BD2A3380BQ35553032-81E1C168-7D28-42B1-A0E9-490496B0B85DQ37579147-E8C1A18F-70FB-45A7-AB46-EEF01AEA83AAQ37991395-AED78D3E-5105-490C-AD0C-042233264DB4Q38000638-9626BC23-E247-4FA8-9ACA-D41D19AB72CDQ38036068-B68C7F8F-CBDA-4AB1-9BAE-7B6103544E9DQ38056164-B60DBDCB-0E7B-44E3-AE69-3075F6408BFFQ38154327-E9D860E1-D8B4-4A01-9F18-1170A123BC0CQ38665824-2EFCF645-04DB-44FD-B66F-AEA990BB2CDAQ38815965-FC8AA68E-FE8A-415A-B758-ECF11D11F6E4Q38929328-017C5BCB-EDF0-41BD-9B45-3F09427FD009Q39480879-E21DEBAC-778D-4D06-ADB3-538674042D61Q40461541-16562C7F-E883-4E6F-92DB-EB73C94D4956Q42249683-D2F9C211-F69E-4545-8346-A1A78F2D0465Q44695400-0F5838D8-09B7-4B3A-A61C-A55E62F31F60Q44881398-08622826-919E-4E37-BF7B-EDE52DF1D734Q45020953-AE75A3CB-B1C6-4EF4-853F-94587F7256DCQ45233931-C70D1C71-46DC-43A0-9B6B-7A1E56E5E1C3Q46791850-98437C4B-763D-4184-B1CD-31842EC225E2Q48629879-D08D0D32-E430-41B3-9B4A-5AE04C99EFFAQ48654145-2CDB657C-C7F2-43CE-8AE6-3CE229E77DA0Q48701263-868F5EDC-466C-4CA6-8C6E-85289AB8E89DQ53131035-E35AD0DA-4BB8-4F30-87CC-AD5314A49EE0Q53276953-16173D04-7B06-4A48-B3E8-1DB9DB3BCD24Q54343269-9E76C1F8-42C9-4D09-A16D-74708D06A2FAQ54374194-F9859D04-F803-426C-BE43-0C2D4B470BF9
P2860
Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors
@ast
Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors
@en
Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors
@nl
type
label
Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors
@ast
Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors
@en
Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors
@nl
prefLabel
Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors
@ast
Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors
@en
Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors
@nl
P3181
P356
P1476
Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors
@en
P2093
Pia Haslund
Robert A Lee
P304
P3181
P356
10.2340/00015555-0747
P407
P50
P577
2009-11-01T00:00:00Z